67 related articles for article (PubMed ID: 20423848)
1. [Expression of the proteins associated with transforming growth factor-beta/Smad signaling pathway in Peutz-Jeghers syndrome].
Wang YJ; Li LJ; Wu BP; Jiang B
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):774-6. PubMed ID: 20423848
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
3. MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma.
Grzmil M; Morin P; Lino MM; Merlo A; Frank S; Wang Y; Moncayo G; Hemmings BA
Cancer Res; 2011 Mar; 71(6):2392-402. PubMed ID: 21406405
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling may be activated in a subset of Peutz-Jeghers syndrome polyps closely correlating to LKB1 expression.
Ma Y; Zhang G; Fu X; Xia O; Zhan C; Li L; Wang Z; Wu B
Oncol Rep; 2010 Jun; 23(6):1569-76. PubMed ID: 20428811
[TBL] [Abstract][Full Text] [Related]
5. LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis.
Katajisto P; Vaahtomeri K; Ekman N; Ventelä E; Ristimäki A; Bardeesy N; Feil R; DePinho RA; Mäkelä TP
Nat Genet; 2008 Apr; 40(4):455-9. PubMed ID: 18311138
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of transforming growth factor-beta signaling pathway in the wall of normal and varicose veins.
Kowalewski R; Malkowski A; Sobolewski K; Gacko M
Pathobiology; 2010; 77(1):1-6. PubMed ID: 20185961
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Peutz-Jeghers polyposis by targeting mammalian target of rapamycin signaling.
Wei C; Amos CI; Zhang N; Wang X; Rashid A; Walker CL; Behringer RR; Frazier ML
Clin Cancer Res; 2008 Feb; 14(4):1167-71. PubMed ID: 18281551
[TBL] [Abstract][Full Text] [Related]
8. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling.
Yu Z; Xing Y
Biochem Biophys Res Commun; 2006 Feb; 340(3):929-34. PubMed ID: 16410076
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity.
Forcet C; Etienne-Manneville S; Gaude H; Fournier L; Debilly S; Salmi M; Baas A; Olschwang S; Clevers H; Billaud M
Hum Mol Genet; 2005 May; 14(10):1283-92. PubMed ID: 15800014
[TBL] [Abstract][Full Text] [Related]
10. Lkb1 is required for TGFbeta-mediated myofibroblast differentiation.
Vaahtomeri K; Ventelä E; Laajanen K; Katajisto P; Wipff PJ; Hinz B; Vallenius T; Tiainen M; Mäkelä TP
J Cell Sci; 2008 Nov; 121(Pt 21):3531-40. PubMed ID: 18840652
[TBL] [Abstract][Full Text] [Related]
11. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB
Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201
[TBL] [Abstract][Full Text] [Related]
12. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
13. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
14. Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?
Lee HG; Ueda M; Zhu X; Perry G; Smith MA
J Neurosci Res; 2006 Dec; 84(8):1856-61. PubMed ID: 16998902
[TBL] [Abstract][Full Text] [Related]
15. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor.
Ferrand N; Atfi A; Prunier C
Cancer Res; 2010 Nov; 70(21):8457-66. PubMed ID: 20959473
[TBL] [Abstract][Full Text] [Related]
16. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
17. A novel de novo mutation in LKB1 gene in a Chinese Peutz Jeghers syndrome patient significantly diminished p53 activity.
Liu L; Du X; Nie J
Clin Res Hepatol Gastroenterol; 2011 Mar; 35(3):221-6. PubMed ID: 21411391
[TBL] [Abstract][Full Text] [Related]
18. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T
Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
[TBL] [Abstract][Full Text] [Related]
19. Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions.
Tsujita-Kyutoku M; Uehara N; Matsuoka Y; Kyutoku S; Ogawa Y; Tsubura A
In Vivo; 2005; 19(6):959-63. PubMed ID: 16277007
[TBL] [Abstract][Full Text] [Related]
20. Differential TGF-{beta} signaling in retinal vascular cells: a role in diabetic retinopathy?
Van Geest RJ; Klaassen I; Vogels IM; Van Noorden CJ; Schlingemann RO
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1857-65. PubMed ID: 19959647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
